Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma

Sponsor
Mayo Clinic
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT03961945
This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma detection, in a screening population, with and without chronic gastroesophageal reflux disease.
Intervention
Sponge Capsule
Condition
Barrett Esophagus, Esophageal Adenocarcinoma
Investigators
Prasad G. Iyer, M.D., Ramona Lansing, R.N., Eduardo Antpack, MD, Ramona Lansing, RN, Rebecca L. Schmidt, R.N., Clinical Trials Referral Office

See list of participating sites